Brand and Other Names:Isuprel
- Classes: Beta1/Beta2 Adrenergic Agonists
Dosing & Uses
Dosage Forms & Strengths
Adams-Stokes Attacks, Cardiac Arrest, or Heart Block
IV bolus: 0.02-0.06 mg (1-3 mL of a 1:50,000 dilution), initially, THEN doses of 0.01-0.2 mg
IV infusion: 5 mcg/min (1.25 mL of a 1:250,000 dilution), initially, THEN doses of 2-20 mcg/min based on patient's response
0.5-5 mcg/min (0.25-2.5 mL of a 1:250,000 dilution) IV infusion
Bronchospasm During Anesthesia
0.01-0.02 mg IV repeat PRN
Other Indications & Uses
Ventricular arrhythmias due to AV block, shock, Adams-Stokes, bronchospasm
Dosage Forms & Strengths
Adams-Stokes Attacks (Off-label)
Usual dose: 0.1-1 mcg/kg/min IV infusion
Heart Block (Off-label)
Usual dose: 0.3 to 1 mcg/kg/min IV infusion
Serious - Use Alternative
Significant - Monitor Closely
Frequency Not Defined
MI size increased
Hypersensitivity, digitalis intoxication, angina pectoris, preexisting cardiac arrhythmias (particularly ventr arrythmias that require inotropic Tx & tachyarrhythmias)
No longer recommended for cardiac arrest
Convulsive disorders, renal disease, CAD, coronary insufficiency, DM, HTN, hyperthyroidism, hyperresponsiveness to sympathomimetic amines, elderly
Questionable efficacy for shock
Not currently Tx of choice
Anesthesia due to cyclopropane or halogenated hydrocarbons
Pregnancy & Lactation
Pregnancy Category: C
Lactation: not known if excreted into breast milk, avoid
A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA:Information not available.
Half-Life: 3-7 hr
Duration: cardiac arrest (IV): 8-50 min
Metabolism: primarily in liver & lung by monoamine oxidase (MAO) & catechol-O-methyl transferase (COMT)
Metabolites: 3-O-methyl-isoproterenol (inactive)
Excretion: urine: 50-80%
Mechanism of Action
Strong beta-1 & beta-2 effects resulting in incr CO, decr PVR, & variable BP & renal perfusion changes
Solution Na-bicarb 5%
Additive: aminophylline, furosemide, NaHCO3
Solution (partial list): D5W, D10W, dextrose-saline, dextrose/LR, NS, ½NS, LR, Ringer's
Additive: atracurium, CaCl2, cimetidine, dobutamine, floxacillin, heparin, MgSO4, KCl, ranitidine, succinylcholine, verapamil, vit B/C
Syringe: ranitidine, caffeine
Y-site: amiodarone, atracurium, bivalirudin, cisatracurium, dexmetedomidine, epinephrine, famotidine, fenoldopam, heparin, hydrocortisone, Hextend, inamrinone, KCl, levofloxacin, milrinone, pancuronium, propofol, remifentanil, Na-nitroprusside, tacrolimus, vecuronium, vit B/C
Adminster by IV infusion (requires infusion pump), or
By direct IV, IM, or SC injection
In extreme emergencies, by intracardiac injection
1 mg (5 mL) in 500 mL D5W (2 mcg/mL) for IV infusion
Store in a cool place between 2-15°C
Protect from light
To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.
Adding plans allows you to:
- View the formulary and any restrictions for each plan.
- Manage and view all your plans together – even plans in different states.
- Compare formulary status to other drugs in the same class.
- Access your plan list on any device – mobile or desktop.
The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.
|1||This drug is available at the lowest co-pay. Most commonly, these are generic drugs.|
|2||This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.|
|3||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.|
|4||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|5||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|6||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|NC||NOT COVERED – Drugs that are not covered by the plan.|
Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
Select a box to add or remove a plan.
Select a class to view formulary status for similar drugs